Melinta Therapeutics, Inc.
(NASDAQ : MLNT)

( )
MLNT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.58%183.626.2%$89.29m
AMRNAmarin Corporation Plc Sponsored ADR
2.03%17.631.8%$87.15m
SAGESAGE Therapeutics, Inc.
0.07%175.398.7%$78.03m
PRGOPerrigo Co. Plc
-0.92%47.336.8%$66.85m
ICPTIntercept Pharmaceuticals, Inc.
2.71%87.8318.6%$65.78m
UTHRUnited Therapeutics Corporation
1.76%87.5014.3%$60.69m
JAZZJazz Pharmaceuticals Plc
-0.48%136.762.3%$59.46m
ZYNEZynerba Pharmaceuticals Inc
-2.59%13.188.3%$40.24m
ICLRICON Plc
1.72%140.904.1%$40.17m
MDCOMedicines Company
1.99%34.8821.8%$40.01m
MNKMallinckrodt Plc
5.71%9.6221.0%$38.56m
CTLTCatalent Inc
0.04%46.212.4%$35.83m
AXSMAxsome Therapeutics, Inc.
4.92%24.732.1%$35.40m
HZNPHorizon Pharma plc
0.94%24.836.7%$35.35m
PCRXPacira Pharmaceuticals, Inc.
0.00%43.3310.5%$33.46m

Company Profile

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.